What is Life Stem Genetics?
, a development stage company, focuses on establishing stem cell therapy based clinics worldwide.
LIFS · Verdict
Moderate reward · moderate risk
LIFS's standout is volatility; profitability and balance sheet weigh on the picture.
Based on 63% data coverage
LIFS · Verdict
Top decile vs peers
0% return on equity
Below average
Model-based scoring. For information only — not financial advice.
, a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases. The company is listed on the PINK in USA, operating in the Financial Services sector, with a market capitalisation of 49.17K.
The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.